2 options
Improving Regulatory Transparency for New Medical Therapies Act.
- Format:
- Book
- Government document
- Author/Creator:
- United States, enacting jurisdiction.
- Language:
- English
- Subjects (All):
- Drugs of abuse--Law and legislation--United States.
- Drugs of abuse.
- Drug approval--United States.
- Drug approval.
- Drugs of abuse--Law and legislation.
- United States.
- Genre:
- statutes.
- law codes.
- Session laws
- Statutes and codes
- Statutes and codes.
- Session laws.
- Physical Description:
- 1 online resource ([6] pages)
- Other Title:
- Act to Amend the Controlled Substances Act with Respect to Drug Scheduling Recommendations by the Secretary of Health and Human Services, and with Respect to Registration of Manufacturers and Distributors Seeking to Conduct Clinical Testing
- Place of Publication:
- [Washington, D.C.] : [U.S. Government Publishing Office], [2015]
- Notes:
- Title from title screen (viewed on Feb. 11, 2016).
- "Nov. 25, 2015 (H.R. 639)"--Page [1].
- "129 Stat. 698"--Page [1].
- "Public Law 114-89."
- Other Format:
- Print version: United States. Improving Regulatory Transparency for New Medical Therapies Act
- OCLC:
- 938650928
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.